2015/07/06 by David Leitsch · 3 citations
Immunology and Microbiology · Medicine · #Parasitic Infections and Diagnostics #Giardia lamblia #Nitazoxanide #Metronidazole #Giardia #Drug resistance #Diarrhea #Parasitology #Coccidia #Parasite hosting #Medicine #Drug #Microbiology #Albendazole #Intestinal parasite #Biology #Antibiotics #Internal medicine #Immunology #Pharmacology #Helminths #Surgery #Pathology
paper · pdf · doi:10.1007/s40475-015-0051-1
openalex publication_date 2015/07/06 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/31
The microaerophilic parasite Giardia lamblia is a causative agent of dysentery affecting hundreds of millions of people around the globe every year. The symptoms of the disease, commonly referred to as giardiasis, are diarrhea, nausea, and malabsorption. Treatment of giardiasis is exclusively based on chemotherapy with antigiardial drugs, including metronidazole, albendazole, and nitazoxanide. In this review, all drugs currently used in the treatment of Giardia infections are discussed with a special emphasis on treatment failure and drug resistance.